Progress in the Development of COVID-19 Therapeutic Reported at a Regular Press Conference by the Governor of Fukuoka Prefecture
Bonac Corporation on August 25th at a regular press conference held by the governor of Fukuoka Prefecture, reported that progress has been made in the development of the COVID-19 therapy, a joint research collaboration with Fukuoka Prefecture and Bonac.
At the press conference, Governor Ogawa reported that experiments using a new coronavirus strain confirmed the therapeutic’s efficacy of against viral infections, and that they have narrowed down the list to three candidate drugs that can be expected to be effective even in small doses. In addition, Mr. Ogawa reported that the project was completed well ahead of schedule.
Governor Ogawa stated, "We have realized that joint research and development that utilizes the strengths of the public and private sectors is very effective. We will continue to work closely with Bonac to accelerate the progress in the future.”
Bonac will work together with Fukuoka Prefecture to deliver the therapeutic drug to patients as soon as possible.